Oncology

New data show that deep-learning classifiers can accurately identify key driver alterations in non-small cell lung cancer…

Key cell cycle genes have been identified as prognostic biomarkers in nasopharyngeal carcinoma, enabling a new prediction model that integrates gene expression with clinical factors to improve survival estimation.

Baseline fatigue reported at treatment initiation is associated with a significantly increased risk of severe, life threatening, and fatal cancer treatment related toxic effects.

Perioperative nivolumab significantly improved survival and pathological response in stage III non-small-cell lung cancer, challenging the traditionally poor prognosis associated with N2 nodal disease.

Using large public datasets including TCGA, GEO and GTEx, researchers found that BAZ2B expression was consistently reduced in several cancer types, with particularly marked downregulation in breast cancer.

AI system surpasses radiologists in detecting pancreatic cancer on CT scans, promising earlier diagnosis and better outcomes.

Prostate cancer remains the most common cancer in men in the UK, with around 55,000 new cases and 12,000 deaths each year and is currently the most common cancer without a national screening programme.

Researchers have identified chromosomal instability in circulating tumour cells as a prognostic and predictive biomarker in metastatic castration resistant prostate cancer.